AN2 Therapeutics (ANTX) Preferred Shares Issued (2021)
AN2 Therapeutics (ANTX) reported Preferred Shares Issued of $79.7 million for Q1 2021.
AN2 Therapeutics (ANTX) Preferred Shares Issued (2021) Analysis & Trends
AN2 Therapeutics (ANTX) has 1 years of Preferred Shares Issued data on file, last reported at $79.7 million in Q1 2021.
- Preferred Shares Issued for Q1 2021 came in at $79.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $79.7 million (changed N/A YoY), and the FY2021 annual result was $79.7 million, changed N/A from the prior year.
- Preferred Shares Issued was little changed at $79.7 million in Q1 2021 per ANTX's latest filing.
- Over five years, Preferred Shares Issued peaked at $79.7 million in Q1 2021 and troughed at $79.7 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | AN2 Therapeutics | 161.95 Mn | 161.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 79.73 Mn |
| Mar 31, 2021 | 79.73 Mn |